Literature DB >> 11833493

Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products.

Leab Sek1, Christopher J H Porter, Ann Marie Kaukonen, William N Charman.   

Abstract

An evaluation of the in-vitro digestion profile and phase behaviour of the common formulation lipids Miglyol 812 (medium chain triglyceride, MCT), Capmul MCM (C8/C10 monoglyceride/ diglyceride mixture), soybean oil (long chain triglyceride, LCT) and Maisine 35-1 (C18 monoglyceride/diglyceride mixture), is described. Experiments were conducted using titrimetric, high-performance thin-layer chromatographic (HPTLC) and ultracentrifugational techniques under model fasted and post-prandial intestinal conditions. The rate and extent of digestion of the medium chain lipids was greater than the corresponding long chain lipids, and independent of bile salt concentration, with complete conversion to monoglyceride and fatty acid occurring after 30 min digestion. The long chain lipid digests separated into an oily phase (containing undigested triglyceride and diglyceride), an aqueous phase (containing bile salt, fatty acid and monoglyceride) and a pellet phase (containing approximately 5 mm of fatty acid, presumably as an insoluble soap) after ultracentrifugation. Higher proportions of long chain fatty acid and monoglyceride were dispersed into the aqueous phase with increasing bile salt concentrations. In contrast, medium chain lipolytic products separated only into an aqueous phase and a pellet fraction in a bile-salt-independent manner. The digestion of both the C8/C10 and C18 monoglyceride/diglyceride lipid mixtures was more rapid than the corresponding triglyceride, especially at early time points. This investigation provides insight into the relative digestion kinetics of medium chain and long chain lipids and provides information regarding the phase behaviour of their lipolytic products under conditions modelled on those expected after oral administration. The data also provide a background for improved understanding of the potential utility of long chain and medium chain lipid-based formulations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833493     DOI: 10.1211/0022357021771896

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  41 in total

1.  Spray Dried Smectite Clay Particles as a Novel Treatment against Obesity.

Authors:  Tahnee J Dening; Paul Joyce; Miia Kovalainen; Hanna Gustafsson; Clive A Prestidge
Journal:  Pharm Res       Date:  2018-12-05       Impact factor: 4.200

2.  Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy.

Authors:  Andrea Rübe; Sandra Klein; Karsten Mäder
Journal:  Pharm Res       Date:  2006-08-10       Impact factor: 4.200

3.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

4.  Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

Authors:  Stephanie Phan; Stefan Salentinig; Clive A Prestidge; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

5.  Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.

Authors:  Kapilkumar Vithani; Adrian Hawley; Vincent Jannin; Colin Pouton; Ben J Boyd
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

6.  Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.

Authors:  Cordula Stillhart; Georgios Imanidis; Martin Kuentz
Journal:  Pharm Res       Date:  2013-02-28       Impact factor: 4.200

7.  Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.

Authors:  Angel Tan; Andrew K Davey; Clive A Prestidge
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

8.  Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.

Authors:  Jianbin Zhang; Yan Lv; Shan Zhao; Bing Wang; Mingqian Tan; Hongguo Xie; Guojun Lv; Xiaojun Ma
Journal:  AAPS PharmSciTech       Date:  2014-02-20       Impact factor: 3.246

Review 9.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

10.  Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.